These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 27753436)

  • 1. Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
    Irvine AJ; Chey WD; Ford AC
    Am J Gastroenterol; 2017 Jan; 112(1):65-76. PubMed ID: 27753436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Chey WD; Talley NJ; Malhotra A; Spiegel BM; Moayyedi P
    Arch Intern Med; 2009 Apr; 169(7):651-8. PubMed ID: 19364994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls.
    Cash BD; Rubenstein JH; Young PE; Gentry A; Nojkov B; Lee D; Andrews AH; Dobhan R; Chey WD
    Gastroenterology; 2011 Oct; 141(4):1187-93. PubMed ID: 21762658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undiagnosed Celiac Disease In Patients Presenting With Irritable Bowel Syndrome Symptoms.
    Khayyat YM
    J Ayub Med Coll Abbottabad; 2020; 32(1):18-23. PubMed ID: 32468748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of serological tests in the diagnosis of celiac disease].
    Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
    Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia.
    Sharma H; Verma AK; Das P; Dattagupta S; Ahuja V; Makharia GK
    J Dig Dis; 2015 Aug; 16(8):443-8. PubMed ID: 25959064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia.
    Dekante A; Daugule I; Pavlovics S; Kikuste I; Polaka I; Tzivian L; Kojalo I; Putnins V; Tolmanis I; Rumba-Rozenfelde I; Boka S; Vanags A; Leja M
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):33-39. PubMed ID: 32176757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study.
    Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM
    Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
    Shalaby SA; Sayed MM; Ibrahim WA; Abdelhakam SM; Rushdy M
    Arab J Gastroenterol; 2016 Jun; 17(2):73-7. PubMed ID: 27349575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive predictive value of serological diagnostic measures in celiac disease.
    Toftedal P; Nielsen C; Madsen JT; Titlestad K; Husby S; Lillevang ST
    Clin Chem Lab Med; 2010 May; 48(5):685-91. PubMed ID: 20201743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study.
    Shayesteh AA; Hajiani E; Hashemi SJ; Masjedizadeh A; Latifi SM; Shayesteh M
    J Dig Dis; 2014 Jan; 15(1):12-7. PubMed ID: 24320042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
    Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome.
    Shamaly H; Hartman C; Pollack S; Hujerat M; Katz R; Gideoni O; Shamir R
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):583-6. PubMed ID: 17460490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease is uncommon in irritable bowel syndrome in the USA.
    Almazar AE; Talley NJ; Larson JJ; Atkinson EJ; Murray JA; Saito YA
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):149-154. PubMed ID: 29240001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of celiac disease in adult Chinese patients with diarrhea-predominant irritable bowel syndrome: A prospective, controlled, cohort study.
    Kou GJ; Guo J; Zuo XL; Li CQ; Liu C; Ji R; Liu H; Wang X; Li YQ
    J Dig Dis; 2018 Mar; 19(3):136-143. PubMed ID: 29451364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.
    Weiss B; Bujanover Y; Avidan B; Fradkin A; Weintraub I; Shainberg B
    Isr Med Assoc J; 2004 Jan; 6(1):9-12. PubMed ID: 14740501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.